Exercise mitigates Dapagliflozin-induced skeletal muscle atrophy in STZ-induced diabetic rats
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are commonly used in the management of type 2 diabetes mellitus (T2DM) and have been found to worsen the reduction of skeletal muscle mass in individuals with... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 12, 2023 Category: Endocrinology Authors: Xudong Yang, Lifeng Wang, Liangzhi Zhang, Xia Zhai, Xiusheng Sheng, Hengjun Lin and Helong Quan Tags: Research Source Type: research
Long-term observation of estimated fluid volume reduction after the initiation of ipragliflozin in patients with type 2 diabetes mellitus: a sub-analysis from a randomized controlled trial (PROTECT)
Recent studies have shown that the addition of sodium-glucose co-transporter 2 (SGLT2) inhibitors gradually reduces the estimated fluid volume parameters in a broad range of patient populations, suggesting tha... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 7, 2023 Category: Endocrinology Authors: Atsushi Tanaka, Takumi Imai, Shigeru Toyoda, Kazuhiro Sugimoto, Ruka Yoshida, Machi Furuta and Koichi Node Tags: Research Source Type: research
Correction: Efficacy of ozone therapy on visual evoked potentials in diabetic patients
(Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 7, 2023 Category: Endocrinology Authors: Morteza Izadi, Mohammad Javanbakht, Ali Sarafzadeh, Behzad Einollahi, Farzaneh Futuhi, Zahra Vahedi, Shi Zhao, Nematollah Jonaidi ‑Jafari, Mahboobeh Sadat Hosseini, Javad Hosseini Nejad, Effat Naeimi, Seyed Hassan Saadat, Hadi Esmaeili Gouvarchin Ghaleh Tags: Correction Source Type: research
Effect of bromocriptine on glycemic control, risk of cardiovascular diseases and weight in patients with type 2 diabetes: a systematic review
Type 2 diabetes (T2DM) patients, including those in good glycemic control, have an increased risk of cardiovascular disease (CVD). Maintaining good glycemic control with drugs may reduce long-term CVD risk. Br... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 6, 2023 Category: Endocrinology Authors: Mulualem Tesfaye Birhan, Teklie Mengie Ayele, Fikire Wondimu Abebe and Fiseha Nigussie Dgnew Tags: Research Source Type: research
Treatment patterns of antidiabetic and kidney protective therapies among patients with type 2 diabetes mellitus and chronic kidney disease in Colombia. The KDICO descriptive study
Type 2 diabetes mellitus is one of the most common causes of chronic kidney disease (CKD) worldwide and prevalence of 1.75 per 100 inhabitants in Colombia. The aim of this study was to describe the treatment p... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 4, 2023 Category: Endocrinology Authors: Manuel E Machado-Duque, Andres Gaviria-Mendoza, Luis F Valladales-Restrepo, Juan Sebastian Franco, Maria de Rosario Forero, David Vizcaya and Jorge E Machado-Alba Tags: Research Source Type: research
Effect of static magnetic field therapy on diabetic neuropathy and quality of life: a double-blind, randomized trial
Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus (DM) that can cause annoying symptoms. To address this condition, several treatment approaches have been proposed, including s... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 4, 2023 Category: Endocrinology Authors: Armin Nazeri, Ali Mohammadpour, Mohammad-Hadi Saeed Modaghegh and Mojtaba Kianmehr Tags: Research Source Type: research
Adipose-derived stem cell exosomes regulate Nrf2/Keap1 in diabetic nephropathy by targeting FAM129B
Exosomes from adipose-derived stem cells (ADSCs-Exos) have exhibited a therapeutic role in diabetic nephropathy (DN). Further studies are needed to investigate how ADSCs-Exos regulate oxidative stress and infl... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 4, 2023 Category: Endocrinology Authors: Peiyao Ren, Fengmei Qian, Lanjun Fu, Wenfang He, Qiang He, Juan Jin and Danna Zheng Tags: Research Source Type: research
Islet transplantation: overcoming the organ shortage
Type 1 diabetes mellitus (T1D) is a condition resulting from autoimmune destruction of pancreatic β cells, leading patients to require lifelong insulin therapy, which, most often, does not avoid the most common c... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 1, 2023 Category: Endocrinology Authors: Marluce da Cunha Mantovani, Ilana Gabanyi, Carlos Andr és Pantanali, Vinícius Rocha Santos, Maria Lúcia Cardillo Corrêa-Giannella and Mari Cleide Sogayar Tags: Research Source Type: research
The role of Huidouba in regulating skeletal muscle metabolic disorders in prediabetic mice through AMPK/PGC-1 α/PPARα pathway
Prediabetes is a transitional state between normal blood glucose levels and diabetes, but it is also a reversible process. At the same time, as one of the most important tissues in the human body, the metaboli... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 1, 2023 Category: Endocrinology Authors: Yu Tian, Dongxu Shi, Haiying Liao, Binan Lu and Zongran Pang Tags: Research Source Type: research
Integrated biomarker profiling of the metabolome associated with type 2 diabetes mellitus among Tibetan in China
Metabolomic signatures of type 2 diabetes mellitus (T2DM) in Tibetan Chinese population, a group with high diabetes burden, remain largely unclear. Identifying the serum metabolite profile of Tibetan T2DM (T-T... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 1, 2023 Category: Endocrinology Authors: Jinli Meng, Fangfang Huang, Jing Shi, Chenghui Zhang, Li Feng, Suyuan Wang, Hengyan Li, Yongyue Guo, Xin Hu, Xiaomei Li, Wanlin He, Jian Cheng and Yunhong Wu Tags: Research Source Type: research
Diabetes duration or age at onset and mortality in insulin-dependent diabetics: a systematic review and meta-analysis
This meta-analysis was conducted given the contradictory findings from studies on the influence of diabetes duration or age at onset on mortality in patients with insulin-dependent diabetes mellitus (IDDM). (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - July 1, 2023 Category: Endocrinology Authors: Xing-mu Wang, Shu-ping Zhong, Gang-feng Li and Fu-yuan Zhuge Tags: Research Source Type: research
Therapeutic effects on the development of heart failure with preserved ejection fraction by the sodium-glucose cotransporter 2 inhibitor dapagliflozin in type 2 diabetes
Heart failure with preserved ejection fraction (HFpEF) is a common disease with high morbidity and lacks effective treatment. We investigated the protective effects of the long-term application of the sodium-g... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - June 29, 2023 Category: Endocrinology Authors: Bin Feng, Peiran Yu, Hao Yu, Buyun Qian, Yuan Li, Kangyun Sun, Bimin Shi, Nannan Zhang and Guidong Xu Tags: Research Source Type: research
12,13-diHOME and noradrenaline are associated with the occurrence of acute myocardial infarction in patients with type 2 diabetes mellitus
Acute myocardial infarction (AMI) is the most prevalent cause of mortality and morbidity in patients with type 2 diabetes mellitus (T2DM). However, strict blood glucose control does not always prevent the deve... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - June 29, 2023 Category: Endocrinology Authors: Ning Cao, Yichun Wang, Boyi Bao, Man Wang, Jiayu Li, Wenxi Dang, Bing Hua, Lijin Song, Hongwei Li and Weiping Li Tags: Research Source Type: research
The triglyceride-glucose index as a potential protective factor for hypertrophic obstructive cardiomyopathy without diabetes: evidence from a two-center study
This study aimed to investigate the relationship between the TyG (Triglyceride-glucose index) and the prognosis of patients with HOCM (hypertrophic obstructive cardiomyopathy) without diabetes. (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - June 29, 2023 Category: Endocrinology Authors: Xiangbin Meng, Jun Gao, Kuo Zhang, Wen Jun, Jing-Jia Wang, Xu-Liang Wang, Yuan-Geng-Shuo Wang, Ji-Lin Zheng, Yu-Peng Liu, Jing-Jing Song, Jie Yang, Yi-Tian Zheng, Chen Li, Wen-Yao Wang, Chunli Shao and Yi-Da Tang Tags: Research Source Type: research
The safety of SGLT-2 inhibitors in diabetic patients submitted to elective percutaneous coronary intervention regarding kidney function: SAFE-PCI pilot study
Percutaneous coronary intervention (PCI) is one of the most performed well-succeeded therapeutic procedures worldwide, reducing symptoms and improving quality of life. Neutrophil Gelatinase-associated Lipocali... (Source: Diabetology and Metabolic Syndrome)
Source: Diabetology and Metabolic Syndrome - June 26, 2023 Category: Endocrinology Authors: Mateus Paiva Marques Feitosa, Eduardo Gomes Lima, Alexandre Ant ônio Cunha Abizaid, Roxana Mehran, Neuza Helena Moreira Lopes, Thiago de Assis Fischer Ramos, Alexandre Hideo-Kajita, Roberto Kalil Filho and Carlos Vicente Serrano Junior Tags: Research Source Type: research
